Expression of MAGE-A4 and MAGE-C1 tumor-associated antigen in benign and malignant thyroid diseases

Head Neck. 2011 Oct;33(10):1426-32. doi: 10.1002/hed.21616. Epub 2011 Jan 18.

Abstract

Background: A subset of thyroid tumors characterized by a follicular growth pattern can represent a serious diagnosis. Immunohistochemistry and molecular pathology for genetic profiling have been used in an attempt to resolve some of these issues.

Methods: Tumor tissue samples of thyroid were obtained from 70 patients who underwent surgical therapy. They were divided into 4 groups: 20 adenomatous goiters, 10 follicular adenomas, 24 papillary carcinomas, and 16 follicular carcinomas. Immunohistochemical analysis was carried out using antibodies for MAGE-A4 (melanoma antigen-encoding gene A4) and MAGE-C1 (melanoma antigen-encoding gene C1).

Results: Standard histologic analysis and immunohistochemistry analysis of MAGE-A4 and MAGE-C1 expression were performed in all patients. The antigens examined were not expressed in any of the tissues.

Conclusions: The malignant degeneration of normal tissues is a multifactorial process, varying considerably both among tumor types and among individual patients. The present study showed that there was no immunolabeling of the MAGE-A4 and MAGE-C1 antigens.

MeSH terms

  • Adenocarcinoma, Follicular / metabolism
  • Adenocarcinoma, Follicular / surgery
  • Adenoma / metabolism
  • Adenoma / surgery
  • Adolescent
  • Adult
  • Antigens, Neoplasm / immunology
  • Antigens, Neoplasm / metabolism*
  • Carcinoma, Papillary / metabolism
  • Carcinoma, Papillary / surgery
  • Female
  • Goiter / metabolism*
  • Goiter / surgery
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Proteins / immunology*
  • Thyroid Neoplasms / metabolism*
  • Thyroid Neoplasms / surgery

Substances

  • Antigens, Neoplasm
  • MAGEA4 protein, human
  • MAGEC1 protein, human
  • Neoplasm Proteins